Wolverine Trading, LLC Protalix Bio Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$1.34 - $1.85 $43,014 - $59,385	32,100 New	32,100 $57,000
Q2 2023 Aug 23, 2023	BUY	$2.0 - $3.36 $283,800 - $476,784	141,900 New	141,900 $283,000
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.37 $13,000 - $17,810	13,000 New	13,000 $18,000
Q2 2022 Aug 15, 2022	BUY	$1.02 - $1.56 $12,240 - $18,720	12,000 New	12,000 $13,000
Q1 2022 May 16, 2022	SELL	$0.81 - $1.17 $18,387 - $26,559	-22,700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.81 - $1.33 $42,282 - $69,426	-52,200 Reduced 69.69%	22,700 $19,000
Q3 2021 Nov 12, 2021	BUY	$1.31 - $1.87 $1,441 - $2,057	1,100 Added 1.49%	74,900 $103,000
Q2 2021 Aug 06, 2021	BUY	$1.86 - $6.22 $102,114 - $341,478	54,900 Added 290.48%	73,800 $141,000
Q1 2021 May 14, 2021	BUY	$3.58 - $6.45 $25,418 - $45,795	7,100 Added 60.17%	18,900 $85,000
Q3 2020 Nov 13, 2020	BUY	$3.37 - $3.93 $39,766 - $46,374	11,800 New	11,800 $46,000
Q2 2020 Aug 13, 2020	SELL	$2.19 - $4.5 $51,027 - $104,850	-23,300 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$2.1 - $4.61 $48,930 - $107,413	23,300 New	23,300 $55,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $89.6M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.